Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Haemonetics (HAE) Amortization of Deferred Charges (2020 - 2024)

Historic Amortization of Deferred Charges for Haemonetics (HAE) over the last 9 years, with Q1 2024 value amounting to $782000.0.

  • Haemonetics' Amortization of Deferred Charges fell 1032.11% to $782000.0 in Q1 2024 from the same period last year, while for Mar 2024 it was $3.2 million, marking a year-over-year increase of 6116.75%. This contributed to the annual value of $3.2 million for FY2024, which is 6116.75% up from last year.
  • Latest data reveals that Haemonetics reported Amortization of Deferred Charges of $782000.0 as of Q1 2024, which was down 1032.11% from $783000.0 recorded in Q4 2023.
  • In the past 5 years, Haemonetics' Amortization of Deferred Charges registered a high of $1.0 million during Q3 2021, and its lowest value of -$484000.0 during Q4 2022.
  • Moreover, its 5-year median value for Amortization of Deferred Charges was $789500.0 (2021), whereas its average is $630500.0.
  • The largest annual percentage gain for Haemonetics' Amortization of Deferred Charges in the last 5 years was 47266.19% (2022), contrasted with its biggest fall of 16095.72% (2022).
  • Haemonetics' Amortization of Deferred Charges (Quarter) stood at $139000.0 in 2020, then skyrocketed by 471.22% to $794000.0 in 2021, then fell by 1.13% to $785000.0 in 2022, then decreased by 0.25% to $783000.0 in 2023, then fell by 0.13% to $782000.0 in 2024.
  • Its last three reported values are $782000.0 in Q1 2024, $783000.0 for Q4 2023, and $780000.0 during Q3 2023.